Endometrial stromal sarcoma: Objective response to letrozole

Gynecologic Oncology

Volumn 82, Issue 2, 2001, Pages 384-388

  Maluf, Fernando Cotait ^a   Sabbatini, Paul ^a   Schwartz, Lawrence ^a   Xia, Jinru ^a   Aghajanian, Carol ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endometrial stromal sarcoma; Estrogen receptor; Letrozole; Low grade sarcoma; Uterine sarcoma

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; GEMCITABINE; IFOSFAMIDE; LETROZOLE; LEUPRORELIN; MEGESTROL ACETATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; EDEMA; ENDOMETRIUM CANCER; FATIGUE; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; STROMA CELL; TREATMENT OUTCOME; UTERUS SARCOMA;

EID: 0034898376     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6238     Document Type: Article

References (10)

1. Retrospective analysis of 318 cases of uterine sarcoma
2. Steroid hormone receptors in endometrial stromal sarcomas: A biochemical and immunohistochemical study
3. Uterine sarcoma: Steroid response to hormonal therapy
4. Endolymphatic stromal myosis: A case with positive estrogen and progesterone receptors and good response to progestins
5. Endolymphatic stromal myosis: Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy
6. Letrozole (Femara), a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate
7. Letrozole, a new potent, selective aromatase inhibitor (AI) superior to aminoglutethimide (AG) in postmenopausal women with advanced breast cancer (ABC) previously treated with antiestrogens
8. Uterine endolymphatic stromal myosis: A collaborative study
9. Endometrial stromal sarcoma: A clinicopathologic study of 11 cases with determination of estrogen and receptor levels in three tumors
10. In vivo measurement of aromatase inhibition by letrozole (CGS20267) in postmenopausal women with breast cancer